SCHEMBL6462939

SCHEMBL6462939

C[C@@H]1CN(Cc2ccc(F)cc2)[C@@H](C)CN1C(=O)COc1ccc(Cl)cc1CS(=O)(=O)[O-].C[C@@H]1CN(Cc2ccc(F)cc2)[C@@H](C)CN1C(=O)COc1ccc(Cl)cc1CS(=O)(=O)[O-].[Ca+2]

nearest known ligand 0.87

Known targets — ChEMBL curated mechanism

GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHMGCRMMP1MMP13MMP7MMP8PTGS1PTGS2ileSpolrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 17/20 0.87
PTGDR2 Q9Y5Y4 3/20 0.56
FPR3 P25089 1/20 0.51
GPR65 Q8IYL9 1/20 0.51
GPR35 Q9HC97 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6466920 0.98 CCR1 (0.87) CCR1PTGDR2FPR3GPR65GPR35
SCHEMBL5060676 0.93 CCR1 (1.00) CCR1PTGDR2FPR3GPR65GPR35
SCHEMBL6076311 0.92 CCR1 (0.85) CCR1PTGDR2FPR3GPR65GPR35
SCHEMBL6465800 0.92 CCR1 (0.98) CCR1PTGDR2FPR3GPR65GPR35
SCHEMBL6078527 0.90 CCR1 (0.81) CCR1PTGDR2FPR3GPR65GPR35
Ethylenediamine SCHEMBL6463190 0.90 CCR1 (0.93) CCR1PTGDR2FPR3GPR65GPR35
SCHEMBL6077571 0.89 CCR1 (0.80) CCR1PTGDR2FPR3GPR65GPR35
SCHEMBL4588384 0.89 CCR1 (0.83) CCR1PTGDR2FPR3GPR65GPR35
SCHEMBL6254939 0.89 CCR1 (0.83) CCR1PTGDR2FPR3GPR65GPR35
SCHEMBL6075709 0.89 CCR1 (0.83) CCR1PTGDR2FPR3GPR65GPR35

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050119275-A1 Salt and crystal forms of (5-chloro-2-{2-[4-(4-fluoro-benzyl)-(2R,5S)-2,5-dimethyl-piperazin-1-yl]-2-oxo-ethoxy}-phenyl)-methanesulfonic acid PFIZER INC. 2005-06-02 US disclosed
WO-2004113311-A1 AMORPHOUS UND CRYSTAL FORMS OF (5-CHLORO-2-{2- PFIZER PRODUCTS INC. (US) 2004-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050119275-A1 Salt and crystal forms of (5-chloro-2-{2-[4-(4-fluoro-benzyl)-(2R,5S)-2,5-dimethyl-piperazin-1-yl]-2-oxo-ethoxy}-phenyl)-methanesulfonic acid CCR1, CCR6, CCR3 CCR1 1/4885PTGDR2 1250/4885FPR3 87/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.